Company profile: Ventripoint Diagnostics
1.1 - Company Overview
Company description
- Provider of knowledge-based heart analysis software. Offerings include VMS+, which creates accurate 3D heart models from 2D echocardiograms and provides cardiac metrics for all four chambers within minutes, and 3D Echo and MRI software installable on any workstation to generate 3D chamber models from commercially available 3D echo or MRI with reproducible, accurate volumetric measurements and ejection fractions.
Products and services
- 3D Echo and MRI Software: Workstation-installed software that builds 3D heart chamber models from commercially available 3D echo or MRI images, delivering reproducible, accurate volumetric measurements and ejection fractions
- VMS+: Echocardiography-derived software that constructs accurate 3D heart models from 2D echocardiograms and rapidly outputs cardiac metrics for all four chambers within minutes
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ventripoint Diagnostics
Occlutech
HQ: Sweden
Website
- Description: Provider of cardiac occlusion devices and other vascular implants, offering the PFO Occluder for patent foramen ovale closure to reduce recurrent stroke, the UNI Occluder for multi-fenestrated atrial septal defects as a surgical alternative, and accessory tools (Pistol Pusher, Flex-II Pusher) for device implantation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Occlutech company profile →
Pathway Medical
HQ: United States
Website
- Description: Provider of medical devices for the treatment of arterial and vascular diseases, designing, developing, manufacturing, and marketing these devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pathway Medical company profile →
Cephea
HQ: United States
Website
- Description: Provider of catheter-delivered mitral valve regurgitation products and heart valves for the treatment of coronary artery disease, offering catheter-based therapies including balloons and stents for aortic valve replacements. Incorporated in 2011 and based in San Jose, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cephea company profile →
Excision Medical
HQ: United States
Website
- Description: Provider of tools for TAVR procedures focused on safe, reliable leaflet modification and excision, device steering, and temporary hemodynamic support. Offerings include the Leaflet Excision System to target and excise aortic valve leaflets and mitigate risks during redo TAVR, Stýri steering catheters, Viking RF Excision Catheter, and HemoShield temporary valve.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Excision Medical company profile →
Minvasys
HQ: France
Website
- Description: Provider of solutions for the treatment of cardiovascular disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Minvasys company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ventripoint Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ventripoint Diagnostics
2.2 - Growth funds investing in similar companies to Ventripoint Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ventripoint Diagnostics
4.2 - Public trading comparable groups for Ventripoint Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →